ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 101 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $52,200,000 | +92.3% | 630,282 | +54.0% | 0.34% | -1.2% |
Q1 2021 | $27,143,000 | -67.0% | 409,341 | -61.8% | 0.34% | -61.1% |
Q4 2020 | $82,164,000 | +4113.5% | 1,070,814 | +3383.7% | 0.88% | +2161.5% |
Q4 2019 | $1,950,000 | +125.2% | 30,738 | 0.0% | 0.04% | +69.6% |
Q3 2019 | $866,000 | -90.1% | 30,738 | -90.7% | 0.02% | -88.6% |
Q2 2019 | $8,765,000 | +44.4% | 330,738 | 0.0% | 0.20% | +17.5% |
Q1 2019 | $6,069,000 | +69.4% | 330,738 | +10.2% | 0.17% | +25.7% |
Q4 2018 | $3,582,000 | -48.9% | 300,000 | -17.9% | 0.14% | -27.3% |
Q3 2018 | $7,006,000 | +41.0% | 365,445 | 0.0% | 0.19% | +43.8% |
Q2 2018 | $4,970,000 | +88.6% | 365,445 | 0.0% | 0.13% | +75.7% |
Q1 2018 | $2,635,000 | +92.1% | 365,445 | -56.9% | 0.07% | +7.2% |
Q2 2017 | $1,372,000 | -12.4% | 847,458 | 0.0% | 0.07% | -22.5% |
Q1 2017 | $1,567,000 | +19.3% | 847,458 | 0.0% | 0.09% | -4.3% |
Q4 2016 | $1,313,000 | -78.9% | 847,458 | 0.0% | 0.09% | -76.9% |
Q3 2016 | $6,228,000 | – | 847,458 | – | 0.40% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |